Home

Recent Articles from GlobeNewswire

Amperfied Selects Lumissil’s CG5317 Green PHY for New DC Fast Charging System
MILPITAS, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- Lumissil, a leading provider of advanced automotive connectivity solutions, announced that Amperfied has selected the CG5317 Green PHY modem for their latest DC charging product. Amperfied, a subsidiary of Heidelberg, officially introduced the new charger on May 7 at a major trade show in Germany.
By Lumissil Microsystems Inc · Via GlobeNewswire · May 13, 2025
STACK Infrastructure Closes $1.4 Billion in Green Financing to Support its Growing Portfolio of Stabilized Hyperscale Assets
Transaction underscores capital providers’ confidence in STACK’s position as a long-term, reliable partner to hyperscale clients
By STACK Infrastructure, Inc. · Via GlobeNewswire · May 13, 2025
Eleva Appoints Donato Spota as Chief Financial Officer
Freiburg im Breisgau, Germany, May 13, 2025 – Eleva, a pioneer in discovering and developing previously inaccessible biologics based on a breakthrough technology platform, appointed Mr. Donato Spota as Chief Financial Officer (CFO) and Managing Director. Mr. Spota brings to Eleva profound expertise in complementary business areas including strategic finance, investor relations, business development and international capital markets transactions. Danielle Püschel, currently serving as CFO, is appointed as Chief Accounting Officer.
By eleva GmbH · Via GlobeNewswire · May 13, 2025
EG 427 highlights at ASGCT major advances made with its HERMES platform in neurology using versatile non-replicative herpes vectors
Paris, France, May 13, 2025 (GLOBE NEWSWIRE) -- EG 427 announced today data highlighting the Company’s leading role in developing non-replicating HSV-1 (nrHSV-1) vector technology in neurology. Data will be presented at the 28th Annual Meeting of the American Society of Cell and Gene Therapy (ASGCT), May 13-17, New Orleans.
By EG 427 · Via GlobeNewswire · May 13, 2025
Progress on share buyback programme
Progress on share buyback programme
By ING Group · Via GlobeNewswire · May 13, 2025
The Stock Exchange of Thailand Expands Strategic Partnership with Nasdaq to Modernize Capital Market Ecosystem
SET to Advance Capital Market Infrastructure with Nasdaq’s Risk and Surveillance Technology
Quadient and Nuvei Sign New Partnership to Enhance Cloud Payment Capabilities for Businesses Globally
Quadient (Euronext Paris: QDT), a global automation platform powering secure and sustainable business connections, and Nuvei, a leading global payments company, today announced a strategic technology partnership to enhance cloud payment capabilities for businesses globally. Through this partnership, Nuvei’s advanced payment processing technology is now integrated into Quadient’s cloud-based Accounts Receivable (AR) and Accounts Payable (AP) automation solutions, providing businesses of all sizes across North America, the UK, and Europe with a unified platform to manage B2B payments more efficiently, securely, and at scale.
By QUADIENT · Via GlobeNewswire · May 13, 2025
CopenPay returns 3 times bigger: Copenhagen now rewards tourists who arrive by train
Copenhagen, May 13, 2025 (GLOBE NEWSWIRE) -- Copenhagen’s green experience economy, CopenPay, is back. The goal is to raise tourists’ awareness about making more sustainable choices. This year, the initiative, which allows visitors to “pay” for experiences across the city with responsible actions, returns three times bigger, running twice as long and rewards guests who travel by train.
By Wonderful Copenhagen · Via GlobeNewswire · May 13, 2025
Galapagos Announces Strategic Update on Proposed Separation, Executive Leadership Transition and Board Changes
Galapagos to re-evaluate the implementation of the previously announced separation following regulatory and market developments
By Galapagos NV · Via GlobeNewswire · May 13, 2025
Jeito Capital leads EUR 132 million oversubscribed Series B financing in Azafaros to advance Phase 3 clinical programs of innovative therapies in rare inherited neuro-metabolic disorders
Jeito Capital leads EUR 132 million oversubscribed Series B financing in Azafaros to advance Phase 3 clinical programs of innovative therapies in rare inherited neuro-metabolic disorders
By Jeito Capital · Via GlobeNewswire · May 13, 2025
Kuros Biosciences to share latest MagnetOs™ market impact and strategic priorities at Capital Market Day in Zürich
    Kuros Biosciences to share latest MagnetOs™ market impact and strategic priorities at Capital Markets Day in Zürich
By Kuros Biosciences AG · Via GlobeNewswire · May 13, 2025
Coastland Dental Introduces Advanced Dental Technology to Enhance Patient Experiences in Burbank
Burbank, CA, May 12, 2025 (GLOBE NEWSWIRE) -- Coastland Dental, a leading dental practice in Burbank, is introducing advanced dental technologies to make dental care more comfortable, efficient, and personalized for patients. By integrating iTero scanning, CAD/CAM same-day restorations, Digital Smile Design, and other technologies, the practice aims to help patients achieve healthier, more confident smiles with greater ease.
By Coastland Dental · Via GlobeNewswire · May 12, 2025
Compass Group Diversified Holdings, LLC Investor Notice: Robbins LLP Reminds Stockholders of the Class Action Lawsuit Against CODI
SAN DIEGO, May 12, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all persons or entities who purchased or otherwise acquired Compass Group Diversified Holdings, LLC (NYSE: CODI) securities between May 1, 2024 and May 7, 2025. Compass is a statutory trust that acquires and manages a group of small and middle-market businesses, including Lugano Holdings, Inc., a designer, manufacturer, and marketer of high-end jewelry.
By Robbins LLP · Via GlobeNewswire · May 12, 2025
CIVI Class Action Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Civitas Resources, Inc. Class Action
SAN DIEGO, May 12, 2025 (GLOBE NEWSWIRE) --
By Robbins LLP · Via GlobeNewswire · May 12, 2025
SXI ALERT: Bragar Eagel & Squire, P.C. is Investigating Standex International Corporation and Encourages Investors to Contact the Firm
NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Standex International Corporation (NYSE:SXI) on behalf of stockholders. Our investigation concerns whether the board of directors of Standex have breached their fiduciary duties to the company.
By Bragar Eagel & Squire · Via GlobeNewswire · May 12, 2025
KRISPY KREME ALERT: Bragar Eagel & Squire, P.C. is Investigating Krispy Kreme, Inc. on Behalf of Krispy Kreme Stockholders and Encourages Investors to Contact the Firm
NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Krispy Kreme, Inc. (“Krispy Kreme” or the “Company”) (NASDAQ:DNUT) on behalf of Krispy Kreme stockholders. Our investigation concerns whether Krispy Kreme has violated the federal securities laws and/or engaged in other unlawful business practices.
By Bragar Eagel & Squire · Via GlobeNewswire · May 12, 2025
SEMTECH ALERT: Bragar Eagel & Squire, P.C. is Investigating Semtech Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Semtech Corporation (NASDAQ:SMTC) on behalf of long-term stockholders following a class action complaint that was filed against Semtech on February 20, 2025 with a Class Period from August 27, 2024 to February 7, 2025. Our investigation concerns whether the board of directors of Semtech have breached their fiduciary duties to the company.
By Bragar Eagel & Squire · Via GlobeNewswire · May 12, 2025
COMPASS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Compass Diversified and Encourages Investors to Contact the Firm
NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Compass Diversified (“Compass” or the “Company”) (NYSE: CODI) in the United States District Court for the Central District of California on behalf of all persons and entities who purchased or otherwise acquired Compass securities between May 1, 2024, and May 7, 2025, both dates inclusive (the “Class Period”). Investors have until July 8, 2025 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
By Bragar Eagel & Squire · Via GlobeNewswire · May 12, 2025
AGCO ALERT: Bragar Eagel & Squire, P.C. is Investigating AGCO Corporation and Encourages Investors to Contact the Firm
NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against AGCO Corporation (NYSE:AGCO) on behalf of stockholders. Our investigation concerns whether the board of directors of AGCO have breached their fiduciary duties to the company.
By Bragar Eagel & Squire · Via GlobeNewswire · May 12, 2025
ESTEE LAUDER ALERT: Bragar Eagel & Squire, P.C. is Investigating The Estee Lauder Companies Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against The Estee Lauder Companies Inc. (NYSE: EL) on behalf of long-term stockholders following a class action complaint that was filed against Estee Lauder on December 7, 2023 with a Class Period from February 3, 2022 to October 31, 2023. Our investigation concerns whether the board of directors of Estee Lauder have breached their fiduciary duties to the company.
By Bragar Eagel & Squire · Via GlobeNewswire · May 12, 2025
DIGIMARC ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Digimarc Corporation and Encourages Investors to Contact the Firm
NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Digimarc Corporation (“Digimarc” or the “Company”) (NASDAQ:DMRC) in the United States District Court for the District of Oregon on behalf of all persons and entities who purchased or otherwise acquired Digimarc securities between May 3, 2024 and February 26, 2025, both dates inclusive (the “Class Period”). Investors have until July 7, 2025 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
By Bragar Eagel & Squire · Via GlobeNewswire · May 12, 2025
NSSC ALERT: Bragar Eagel & Squire, P.C. is Investigating Napco Security Technologies, Inc. and Encourages Investors to Contact the Firm
NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Napco Security Technologies, Inc. (NASDAQ:NSSC) on behalf of stockholders. Our investigation concerns whether the board of directors of Napco have breached their fiduciary duties to the company.
By Bragar Eagel & Squire · Via GlobeNewswire · May 12, 2025
WST Class Action Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the West Pharmaceutical Services, Inc. Class Action
SAN DIEGO, May 12, 2025 (GLOBE NEWSWIRE) --
By Robbins LLP · Via GlobeNewswire · May 12, 2025
Prime Mining Reports Q1 2025 Financial and Operating Results
VANCOUVER, British Columbia, May 12, 2025 (GLOBE NEWSWIRE) -- Prime Mining Corp. (“Prime” or the “Company”) (TSV: PRYM) (OTCQX: PRMNF) (Frankfurt: O4V3) is pleased to report its operating and financial results for the quarter ended March 31, 2025. Prime is focused on the exploration and development of its wholly owned high-grade Los Reyes Gold-Silver Project in Sinaloa State, Mexico (“Los Reyes” or the “Project”).
By Prime Mining Corp. · Via GlobeNewswire · May 12, 2025
CTS Corporation Declares a Dividend
LISLE, Ill., May 12, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of CTS Corporation (NYSE: CTS) has declared a cash dividend of $0.04 per share on outstanding shares of common stock, without par value, to be paid on July 25, 2025, to shareholders of record at the close of business on June 27, 2025.
By CTS Corporation · Via GlobeNewswire · May 12, 2025
Introducing Samsung Galaxy S25 Edge on Verizon
Get a Verizon 3-year price-lock guarantee and a new Galaxy S25 Edge on us with myPlan and any trade-in from Apple, Google or Samsung
HighPeak Energy, Inc. Announces First Quarter 2025 Financial and Operating Results - AMENDED
FORT WORTH, Texas, May 12, 2025 (GLOBE NEWSWIRE) -- HighPeak Energy, Inc. (“HighPeak” or the “Company”) (NASDAQ: HPK) today announced amended financial and operating results for the quarter ended March 31, 2025, provided an updated 2025 development outlook and increased production guidance. Please note that in the Unaudited Condensed Consolidated Statements of Cash Flows table, the amount of Repayments under Term Loan Credit Agreement for 2025 was amended from (120,000) to (30,000). The amended release follows:
By HighPeak Energy, Inc. · Via GlobeNewswire · May 12, 2025
Catheter Precision, Inc. Announces $1.5 Million Private Placement Equity Financing and Potential Strategic Alliance
Fort Mill, S.C., May 12, 2025 (GLOBE NEWSWIRE) -- Catheter Precision (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market, today announced that it has entered into securities purchase agreements with institutional investors for a $1.5 million private placement equity financing and the acquisition of certain promissory notes of QHSLab, Inc.
By Catheter Precision, Inc. · Via GlobeNewswire · May 12, 2025
New Home Co. to Acquire Landsea Homes Corporation, Creating a Top 25 National Homebuilder
Landsea Homes Shareholders to Receive $11.30 Per Share in Cash, Representing a Premium of Approximately 61% to the Closing Share Price on May 12, 2025
Apimeds Pharmaceuticals US, Inc. Announces Closing of Initial Public Offering
Hopewell, New Jersey, May 12, 2025 (GLOBE NEWSWIRE) -- Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) (“Apimeds” or the “Company”), a clinical stage biopharmaceutical company that is in the process of developing Apitox, an intradermally administered bee venom-based toxin which potentially exhibits diverse therapeutic effects, today announced the closing of its initial public offering (the “Offering”) of 3,375,000 shares of common stock at a public offering price of $4.00 per share. The shares began trading on the NYSE American on May 9, 2025, under the symbol “APUS.” 
Legacy Housing Corporation Reports First Quarter 2025 Financial Results
BEDFORD, Texas, May 12, 2025 (GLOBE NEWSWIRE) -- Legacy Housing Corporation (“Legacy” or the “Company,” NASDAQ: LEGH) today announced its financial results for the first quarter ended March 31, 2025.
By Legacy Housing Corporation · Via GlobeNewswire · May 12, 2025
iAnthus Reports First Quarter 2025 Financial Results
NEW YORK and TORONTO, May 12, 2025 (GLOBE NEWSWIRE) -- iAnthus Capital Holdings, Inc. (“iAnthus” or the “Company”) (CSE: IAN, OTCQB: ITHUF), which owns, operates, and partners with regulated cannabis operations across the United States, today reported its financial results for the first quarter ended March 31, 2025. The Company’s Quarterly Report on Form 10-Q (the “Quarterly Report”), which includes its unaudited interim condensed consolidated financial statements for the first quarter ended March 31, 2025 and the related management’s discussion and analysis of financial condition and results of operations, can be accessed on the Securities and Exchange Commission’s (“SEC’s”) website at www.sec.gov, on the System for Electronic Document Analysis and Retrieval's (SEDAR+) website at www.sedarplus.com, and on the Company’s website at www.iAnthus.com. The Company’s financial statements are reported in accordance with U.S. generally accepted accounting principles (“GAAP”). All currency is expressed in U.S. dollars.
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BEDFORD, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in the osteoarthritis (“OA”) pain management and regenerative solutions spaces focused on early intervention orthopedics, today announced that on May 1, 2025, Anika granted non-statutory stock options (“Options”) covering an aggregate of 5,000 shares of common stock at a per share exercise price of $14.46, which equaled the closing price of common stock on the Nasdaq Global Select Market (“Closing Price”) on the grant date, to two newly hired non-executive employees. The grants were made pursuant to the Anika Therapeutics, Inc. 2021 Inducement Plan, as amended, were approved by the compensation committee of the board of directors pursuant to a delegation of authority by the board of directors, and, in accordance with Nasdaq Listing Rule 5635(c)(4), were made as a material inducement to the grantee’s acceptance of employment with Anika as a component of the grantee’s employment compensation.
By Anika Therapeutics Inc. · Via GlobeNewswire · May 12, 2025
Cheer Holding, Inc. Announces Results of its Annual General Meeting
BEIJING, May 12, 2025 (GLOBE NEWSWIRE) -- Cheer Holding, Inc. (NASDAQ: CHR) (“Cheer Holding” or the “Company”), a leading provider of advanced mobile internet infrastructure and platform services, today announced the results of its 2025 Annual General Meeting, which was held on May 12, 2025 in Beijing, China.
By Cheer Holding, Inc. · Via GlobeNewswire · May 12, 2025
Microvast Reports First Quarter 2025 Financial Results
STAFFORD, Texas, May 12, 2025 (GLOBE NEWSWIRE) -- Microvast Holdings, Inc. (NASDAQ:MVST) (“Microvast” or the “Company”), a global leader in advanced battery technologies, announced today its unaudited condensed consolidated financial results for the first quarter ended March 31, 2025 (“Q1 2025”).
By Microvast, Inc. · Via GlobeNewswire · May 12, 2025
Quipt Home Medical Reports Fiscal Second Quarter 2025 Results
Posts Strong Adjusted EBITDA of 23.3% of Revenue
By Quipt Home Medical Corp. · Via GlobeNewswire · May 12, 2025
AirJoule Technologies Announces First Quarter 2025 Results
RONAN, Mont., May 12, 2025 (GLOBE NEWSWIRE) -- AirJoule Technologies Corporation (NASDAQ: AIRJ) (“AirJoule Technologies” or the “Company”), the developer of the transformational AirJoule® system for separating pure water from air, today announced its first quarter 2025 results.
Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PHILADELPHIA, May 12, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging bispecific antibodies for solid tumors, today announced that Context has granted non-qualified stock option awards to purchase an aggregate of 160,000 shares of its common stock to two new employees as an inducement material for accepting employment with Context.
By Context Therapeutics Inc. · Via GlobeNewswire · May 12, 2025
ZyVersa Therapeutics Reports First Quarter 2025 Financial Results and Highlights Pipeline Progress
KEY HIGHLIGHTS
By ZyVersa Therapeutics · Via GlobeNewswire · May 12, 2025
The Kennedy Forum Leads with Action After Admin Announcement Reconsidering 2024 Parity Rule
Washington, D.C., May 12, 2025 (GLOBE NEWSWIRE) -- In a significant policy shift, the Trump Administration stated that it plans not to enforce, and then ultimately reconsider, the 2024 Mental Health and Substance Use Disorder Parity Final Rule. The Kennedy Forum will engage with the Administration and the field across a series of actions to support the transition for tens of millions of Americans who seek treatment and medication for mental health conditions and substance use disorders each year.
By The Kennedy Forum · Via GlobeNewswire · May 12, 2025
NIP Group Inc. Filed 2024 Annual Report on Form 20-F
ABU DHABI, United Arab Emirates, May 12, 2025 (GLOBE NEWSWIRE) -- NIP Group Inc. (“NIPG” or the “Company”) (NASDAQ: NIPG), a leading digital entertainment company, today announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2024 with the Securities and Exchange Commission (the "SEC") on May 12, 2025.
By NIP GROUP INC. · Via GlobeNewswire · May 12, 2025
Stran & Company Schedules First Quarter 2025 Financial Results and Business Update Conference Call
Quincy, MA, May 12, 2025 (GLOBE NEWSWIRE) -- Stran & Company, Inc. ("Stran" or the "Company") (NASDAQ: SWAG) (NASDAQ: SWAGW), a leading outsourced marketing solutions provider that leverages its promotional products and loyalty incentive expertise, today announced it will host a conference call at 10:00 A.M. Eastern Time on Friday, May 16, 2025, to discuss the Company’s financial results for the first quarter of 2025 ended March 31, 2025, as well as the Company’s corporate progress and other developments.
By Stran & Company, Inc. · Via GlobeNewswire · May 12, 2025
Editas Medicine Announces First Quarter 2025 Results and Business Updates
Company to share in vivo preclinical data demonstrating the successful use of targeted lipid nanoparticles to deliver HBG1/2 promoter editing cargo to hematopoietic stem and progenitor cells (HSPCs) at ASGCT this week
By Editas Medicine, Inc. · Via GlobeNewswire · May 12, 2025
Life360 Reports Record Q1 2025 Results
Monthly Active Users Reached Approximately 83.7 millionRecord Q1 Global Net Additions to Paying Circles of 137 thousand - Reaching 2.4 million TotalTotal Quarterly Revenue Grew 32% Year-Over-Year to $103.6 millionAnnualized Monthly Revenue increased 38% Year-Over-Year to $393.0 million
By Life360, Inc. · Via GlobeNewswire · May 12, 2025
Satellogic Secures Multi-Million Dollar Agreement with Asia Pacific Customer
Agreement Unlocks Advanced Monitoring Capabilities Through Satellogic’s NewSat Fleet and Aleph Platform
By Satellogic, Inc. · Via GlobeNewswire · May 12, 2025
Cellectis Reports Financial Results for the First Quarter 2025
NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to develop life-saving cell and gene therapies, today provided financial results for the first quarter 2025, ending March 31, 2025, and provided a business update.
By Cellectis Inc. · Via GlobeNewswire · May 12, 2025
Altus Group Announces Q2 2025 Dividend Payment
TORONTO, May 12, 2025 (GLOBE NEWSWIRE) -- Altus Group Limited (ʺAltus Group” or “the Company”) (TSX: AIF), a leading provider of commercial real estate (“CRE”) intelligence, announced today that its Board of Directors approved the payment of a cash dividend of $0.15 per common share for the second quarter ending June 30, 2025. Payment will be made on July 15, 2025 to common shareholders of record as at June 30, 2025.
By Altus Group Limited · Via GlobeNewswire · May 12, 2025
Jones Soda Sets First Quarter 2025 Conference Call for Thursday, May 15, 2025, at 4:30 p.m. ET
SEATTLE, May 12, 2025 (GLOBE NEWSWIRE) -- Jones Soda Co. (CSE: JSDA, OTCQB: JSDA) (“Jones Soda” or the “Company”), today announced it will hold a conference call on Thursday, May 15, 2025, at 4:30 p.m. Eastern time to discuss its financial and operational results for the first quarter ended March 31, 2025. The financial results will be reported in a press release prior to the conference call.
By Jones Soda Co. · Via GlobeNewswire · May 12, 2025
Vireo Growth Inc. Announces Closing of WholesomeCo Cannabis & Arches Merger Transactions
– Acquisitions strengthen profitability and competitive position with proprietary technology platform –
By Vireo Growth Inc. · Via GlobeNewswire · May 12, 2025
Orchestra BioMed Reports First Quarter 2025 Financial Results and Highlights Recent Regulatory and Clinical Milestones
NEW HOPE, Pa., May 12, 2025 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced financial results for the first quarter ended March 31, 2025, and provided a business update highlighting continued regulatory momentum, disciplined operational execution, and a strengthening clinical development pipeline.
ODDITY Announces Block Trade of Class A Ordinary Shares
NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- ODDITY Tech Ltd. (the “Company”) (NASDAQ: ODD) today announced the sale of 5,500,000 shares of its Class A ordinary shares by an entity affiliated with Oran Holtzman, ODDITY co-founder and CEO.
By Oddity Tech Ltd. · Via GlobeNewswire · May 12, 2025
Coherus BioSciences Reports First Quarter 2025 Financial Results and Provides Business Update
– Strategic transformation to innovative oncology completed in Q2 2025 –
By Coherus BioSciences, Inc. · Via GlobeNewswire · May 12, 2025
ProKidney Reports First Quarter 2025 Financial Results and Business Highlights
WINSTON-SALEM, N.C., May 12, 2025 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company"), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD), today reported financial results and business highlights for the first quarter ended March 31, 2025.
By ProKidney · Via GlobeNewswire · May 12, 2025
Royalty Pharma Announces Shareholder Approval of its External Manager Acquisition
NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that shareholders overwhelmingly approved its previously announced external manager acquisition, with 99.9% voting in favor at Royalty Pharma’s 2025 Annual General Meeting and Special Meeting of Shareholders (the “Meeting”), marking a key milestone for the company.
By Royalty Pharma plc · Via GlobeNewswire · May 12, 2025
Matthews International Announces Acquisition of the Dodge Company
PITTSBURGH, May 12, 2025 (GLOBE NEWSWIRE) -- Matthews Memorialization, a division of Matthews International Corporation (NASDAQ GSM: MATW) (“Matthews”), today announced it has acquired The Dodge Company (“Dodge”) for $57 Million. Dodge is a leading supplier of embalming chemicals and supplies in North America and sells a variety of other related products to Funeral Homes. Matthews Memorialization is a leading supplier to Funeral Homes and Cemeteries in North America, selling a broad range of products including caskets, bronze and granite memorials, and cremation equipment. The acquisition advances Matthews’ strategy of providing a comprehensive product offering to its death care industry customers.
Atea Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update
Enrollment Ongoing in Phase 3 C-BEYOND Trial for Treatment of HCV
By Atea Pharmaceuticals, Inc. · Via GlobeNewswire · May 12, 2025
Natural Gas Services Group, Inc. Reports First Quarter 2025 Financial and Operating Results; Increases 2025 Guidance
Midland, Texas, May 12, 2025 (GLOBE NEWSWIRE) -- Natural Gas Services Group, Inc. (“NGS” or the “Company”) (NYSE:NGS), a leading provider of natural gas compression equipment, technology, and services to the energy industry, today announced financial results for the three months ended March 31, 2025. The Company also raised the high-end of its full-year 2025 Adjusted EBITDA guidance to $79 million, citing continued strength in its business and growing demand across its fleet.
Getty Images Reports First Quarter 2025 Results
NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- Getty Images Holdings, Inc. (“Getty Images” or the “Company”) (NYSE: GETY), a preeminent global visual content creator and marketplace, today reported financial results for the first quarter ended March 31, 2025.
By Getty Images, Inc. · Via GlobeNewswire · May 12, 2025
Exodus Reports First Quarter 2025 Results
First Quarter 2025 Revenue of $36.0 million; Highest Q1 in History
By Exodus · Via GlobeNewswire · May 12, 2025
Maravai Lifesciences Reports First Quarter 2025 Financial Results
SAN DIEGO, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the first quarter ended March 31, 2025, together with other business updates.
Rigetti Computing Reports First Quarter 2025 Financial Results
BERKELEY, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- Rigetti Computing, Inc. (Nasdaq: RGTI) (“Rigetti” or the “Company”), a pioneer in full-stack quantum-classical computing, today announced its financial results for the first quarter ended March 31, 2025.
By Rigetti Computing, Inc. · Via GlobeNewswire · May 12, 2025
Runway Growth Finance Corp. Reports First Quarter 2025 Financial Results
Delivered Total and Net Investment Income of $35.4 million and $15.6 million, Respectively
By Runway Growth Finance Corp. · Via GlobeNewswire · May 12, 2025
Onco360 Has Been Selected as a National Specialty Pharmacy Partner for AVMAPKI™FAKZYNJA™ CO-PACK
LOUISVILLE, Ky., May 12, 2025 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent specialty pharmacy, has been selected as a national pharmacy partner by Verastem Oncology for AVMAPKI™ FAKZYNJA™ CO-PACK (avutometinib capsules; defactinib tablets), for the treatment of adult patients with KRAS-mutated recurrent low-grade serous ovarian cancer (LGSOC) who have received prior systemic therapy.1 This indication was approved on March 8th, 2025 based on the Phase 2 RAMP-201 study in adults (≥18 years of age) with low grade serous ovarian cancer.2
By Onco360 Oncology Pharmacy · Via GlobeNewswire · May 12, 2025
Amplify Energy Announces First Quarter 2025 Results, Beta Development Update and Updated Full-Year 2025 Guidance
HOUSTON, May 12, 2025 (GLOBE NEWSWIRE) -- Amplify Energy Corp. (NYSE: AMPY) (“Amplify,” the “Company,” “us,” or “our”) announced today its operating and financial results for the first quarter of 2025 and updated full-year 2025 guidance for the Company.
By Amplify Energy Corp. · Via GlobeNewswire · May 12, 2025
Bolt Biotherapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
REDWOOD CITY, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer, today reported financial results for the first quarter ended March 31, 2025, and provided a business update. “We continue to make progress advancing our pipeline of first-in-class, novel immunotherapies,” said Willie Quinn, Chief Executive Officer. “We recently presented promising early clinical data for BDC-3042 at AACR and launched a process to find a partner to accelerate BDC-3042 development. We also just opened enrollment for the first next-generation Boltbody™ ISAC in our pipeline, BDC-4182. We are excited to see what our ISAC platform technology can do for gastric and gastroesophageal cancer patients. We continue to be good stewards of capital as we execute against our mission to deliver new treatment options to patients with cancer.”
By Bolt Biotherapeutics, Inc. · Via GlobeNewswire · May 12, 2025
GigaCloud Technology Inc Announces First Quarter Ended March 31, 2025 Financial Results
Continued B2B Marketplace Expansion and Proven Strength of the SFR Model
By GigaCloud Technology · Via GlobeNewswire · May 12, 2025
OptimizeRx Reports First Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance
WALTHAM, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today reported results for the three months ended March 31, 2025. Quarterly comparisons are to the same year-ago period.
By OptimizeRx Corporation · Via GlobeNewswire · May 12, 2025
Akoya Biosciences Reports First Quarter 2025 Financial Results
MARLBOROUGH, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced its financial results for the first quarter ending March 31, 2025.
By Akoya Biosciences, Inc. · Via GlobeNewswire · May 12, 2025
Viasat Announces Appointments of Bill LaPlante and Michael Paull to Its Board of Directors
CARLSBAD, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- Viasat, Inc. (NASDAQ: VSAT), a global leader in satellite communications, today announced the appointments of  Dr. William “Bill” LaPlante and Michael Paull to its Board of Directors, effective immediately.
By Viasat, Inc. · Via GlobeNewswire · May 12, 2025
Sana Biotechnology to Present at the BofA Securities 2025 Healthcare Conference
SEATTLE, May 12, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentation at the BofA Securities 2025 Healthcare Conference at 9:20 a.m. PT on Tuesday, May 13, 2025. The presentation will feature a business overview and update by Steve Harr, Sana’s President and Chief Executive Officer.
By Sana Biotechnology, Inc · Via GlobeNewswire · May 12, 2025
Rapid7 Announces First Quarter 2025 Financial Results
BOSTON, May 12, 2025 (GLOBE NEWSWIRE) -- Rapid7, Inc. (Nasdaq: RPD), a leader in extended risk and threat detection, today announced its financial results for the first quarter 2025.
By Rapid7 · Via GlobeNewswire · May 12, 2025
Black Diamond Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
CAMBRIDGE, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer, today reported financial results for the first quarter ended March 31, 2025, and provided a corporate update.
Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q1 Financial Results
Completed enrollment in Phase 2 MaGic trial of DNTH103 in generalized Myasthenia Gravis (gMG)
By Dianthus Therapeutics, Inc. · Via GlobeNewswire · May 12, 2025
MidCap Financial Investment Corporation Reports Financial Results for the Quarter Ended March 31, 2025
Results for the Quarter Ended March 31, 2025 and Other Recent Highlights:
Resolute Holdings Reports First Quarter 2025 Results
NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- Resolute Holdings Management, Inc. (“Resolute Holdings”) (Nasdaq: RHLD), an operating management company responsible for providing management services to CompoSecure Holdings, L.L.C. (“CompoSecure Holdings”), a wholly owned subsidiary of CompoSecure, Inc. (“CompoSecure”) (Nasdaq: CMPO), today reported financial results for its fiscal first quarter ending March 31, 2025. Resolute Holdings reported first quarter earnings per share attributable to common stockholders of ($0.39) and Non-GAAP Fee-Related Earnings per share of ($0.07).